Cholestyramine for Oral Suspension
NDC 62135-008, Cholestyramine for Oral Suspension, powder, from Chartwell RX, LLC.
- Product NDC
- 62135-008
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- POWDER
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074561
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-008-56 | 62135000856 | 378 g in 1 CAN (62135-008-56) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/80db0042-0c05-4509-8a6b-fa9f4783629aNADAC price for package 62135000856
GET /v1/drugs/nadac/62135000856
Use it
Look up 62135-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.